The use of anti-PD-1 and anti-PD-L1 has most frequently been linked to acute tubulo-interstitial nephritis, with diffuse tubulo-interstitial infiltrate of lymphocytes (mostly CD3+, CD4+), eosinophils and plasma cells. Here, CD274 is linked to nephritis.